Sep 15, 2022

Featuring perspectives from Dr Stephen Ansell, including the following topics:

• Evolution of first-line management of advanced Hodgkin lymphoma (HL) (0:00)
• Transplant strategies and outcomes for patients with relapsed/refractory HL (4:20)
• Chemoimmunotherapy options for patients with HL (8:06)
• Current and future management of limited-stage disease (11:52)
• Addition of antibody-drug conjugates to HL treatment strategies (22:52)
• Long-term management of HL (29:16)
• Future management of HL — novel agents and strategies (34:56)

CME information and select publications